Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies

被引:9
|
作者
Masaracchia, Caterina [1 ]
Koenig, Annekatrin [1 ]
Valiente-Gabioud, Ariel A. [2 ,3 ]
Peralta, Pablo [2 ,3 ]
Favretto, Filippo [4 ]
Strohaeker, Timo [5 ]
Lazaro, Diana F. [1 ]
Zweckstetter, Markus [4 ,5 ,6 ]
Fernandez, Claudio O. [2 ,3 ]
Outeiro, Tiago F. [1 ,7 ,8 ]
机构
[1] Univ Med Ctr Gottingen, Dept Expt Neurodegenerat, Ctr Nanoscale Microscopy & Mol Physiol Brain, Ctr Biostruct Imaging Neurodegenerat, Gottingen, Germany
[2] UNR, MPIbpC, MPLbioR, Max Planck Lab Struct Biol Chem & Mol Biophys Ros, S2002LRK, Rosario, Santa Fe, Argentina
[3] UNR, CONICET, IIDEFAR, Inst Invest Descubrimiento Farmacos Rosario, S2002LRK, Rosario, Santa Fe, Argentina
[4] German Ctr Neurodegenerat Dis DZNE, Von Siebold Str 3a, D-37075 Gottingen, Germany
[5] Univ Gottingen, Univ Med Ctr Gottingen, Dept Neurol, Waldweg 33, D-37073 Gottingen, Germany
[6] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany
[7] Max Planck Inst Expt Med, Gottingen, Germany
[8] Newcastle Univ, Inst Neurosci, Med Sch, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2020年 / 1868卷 / 01期
关键词
Alpha-synuclein; Parkinson's disease; Neurodegeneration; Protein aggregation; Misfolding; LEWY BODY; AMINO-ACIDS; RANDOM COIL; BINDING; ACCUMULATION; INCLUSIONS; PEPTIDE; NMR; NEURODEGENERATION; FIBRILLIZATION;
D O I
10.1016/j.bbapap.2019.140298
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The misfolding and aggregation of alpha-synuclein (aSyn) are thought to be central events in synucleinopathies. The physiological function of aSyn has been related to vesicle binding and trafficking, but the precise molecular mechanisms leading to aSyn pathogenicity are still obscure. In cell models, aSyn does not readily aggregate, even upon overexpression. Therefore, cellular models that enable the study of aSyn aggregation are essential tools for our understanding of the molecular mechanisms that govern such processes. Here, we investigated the structural features of SynT, an artificial variant of aSyn that has been widely used as a model of aggregation in mammalian cell systems, since it is more prone to aggregation than aSyn. Using Nuclear Magnetic Resonance (NMR) spectroscopy we performed a detailed structural characterization of SynT through a systematic comparison with normal, unmodified aSyn. Interestingly, we found that the conformations adopted by SynT resemble those described for the unmodified protein, demonstrating the usefulness of SynT as a model for aSyn aggregation. However, subtle differences were observed at the N-terminal region involving transient intra and/or intermolecular interactions that are known to regulate aSyn aggregation. Importantly, our results indicate that disturbances in the N-terminal region of SynT, and the consequent decrease in membrane binding of the modified protein, might contribute to the observed aggregation behavior of aSyn, and validate the use of SynT, one of the few models of aSyn aggregation in cultured cells.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Alpha-synuclein aggregation in Gaucher patients and carriers with synucleinopathies
    Choi, Jae
    Stubblefield, Barbara
    Goker-Alpan, Ozlem
    Cookson, Mark
    Tayebi, Nahid
    Sidransky, Ellen
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S14 - S14
  • [2] Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic
    Hassanzadeh, Kambiz
    Morrone, Castrese
    Akhtari, Keivan
    Gerhardt, Ellen
    Zaccagnini, Ludovica
    Outeiro, Tiago Fleming
    Feligioni, Marco
    MECHANISMS OF AGEING AND DEVELOPMENT, 2023, 209
  • [3] Single Molecule Characterization of α-Synuclein in Aggregation-Prone States
    Trexler, Adam J.
    Rhoades, Elizabeth
    BIOPHYSICAL JOURNAL, 2010, 99 (09) : 3048 - 3055
  • [4] Detection of alpha-synuclein aggregation from submandibular and esophageal tissue of patients with synucleinopathies
    Yamasaki, T.
    Sudhakar, T.
    Ostrakhovitch, E.
    Song, E.
    MOVEMENT DISORDERS, 2020, 35 : S233 - S233
  • [5] Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
    Rcom-H'cheo-Gauthier, Alexandre N.
    Osborne, Samantha L.
    Meedeniya, Adrian C. B.
    Pountney, Dean L.
    FRONTIERS IN NEUROSCIENCE, 2016, 10
  • [6] Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
    Javanshiri, Keivan
    Drakenberg, Tove
    Haglund, Mattias
    Englund, Elisabet
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) : 1125 - 1131
  • [7] Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
    Okita, Yuho
    Rcom-H'cheo-Gauthier, Alexandre N.
    Goulding, Michael
    Chung, Roger S.
    Faller, Peter
    Pountney, Dean L.
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [8] Cutaneous Alpha-Synuclein Deposition Across the Synucleinopathies
    Gibbons, Christopher
    Wang, Ningshan
    Rajan, Sharika
    Kern, Drew
    Palma, Jose-Alberto
    Kaufmann, Horacio
    Freeman, Roy
    NEUROLOGY, 2020, 94 (15)
  • [9] Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
    Sandoval, Ivette M.
    Marmion, David J.
    Meyers, Kimberly T.
    Manfredsson, Fredric P.
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 : S189 - S197
  • [10] Biochemical Differences in Pathologic alpha-Synuclein in Synucleinopathies
    Yamasaki, Tritia R.
    Welleford, Andrew S.
    Gerhardt, Greg A.
    ANNALS OF NEUROLOGY, 2017, 82 : S180 - S180